Increasing aclarubicin dosage of the conventional CAG (low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor) regimen is more efficacious as a salvage therapy than CAG for relapsed/refractory acute myeloid leukemiaQi Qu, Depei Wu, Limin Liu et al.|Leukemia Research|2015Cited by 12
Comparison of Haploidentical Hematopoietic Stem Cell Transplant With or Without Unrelated Cord Blood Infusion in Severe Aplastic Anemia: Outcomes of a Multicenter StudyMeiqing Lei, Depei Wu, Yanming Zhang et al.|Frontiers in Immunology|2022Cited by 9
Efficacy of cytarabine, aclarubicin and granulocyte colony-stimulating factor (CAG) regimen compared to FLAG regimen for adult patients with relapsed/refractory Philadelphia chromosome-negative acute lymphoblastic leukemiaXiaoli Li, Depei Wu, Limin Liu et al.|Leukemia Research|2015Cited by 7